Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

14.16HKD
11:56am IST
Change (% chg)

HK$0.20 (+1.43%)
Prev Close
HK$13.96
Open
HK$14.18
Day's High
HK$14.26
Day's Low
HK$14.02
Volume
8,137,236
Avg. Vol
25,774,380
52-wk High
HK$15.92
52-wk Low
HK$6.07

Chart for

About

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products... (more)

Overall

Beta: 0.41
Market Cap(Mil.): HK$64,856.68
Shares Outstanding(Mil.): 7,412.19
Dividend: 0.02
Yield (%): 0.74

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing​ & Super Demand

* CO TO ACQUIRE SINO BIOPHARM BEIJING​,WHICH OWNS 33.6% OF BEIJING TIDE, BY ISSUING 723.3 MILLION SHARES AT HK$12.73 PER ISSUE SHARE

05 Jan 2018

BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​

* "TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​

05 Dec 2017

BRIEF-Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln

* ‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​

09 Nov 2017

Earnings vs. Estimates